OPINION BY WILLIAM HASELTINE
Vaccine distribution in the United States to this point has been inefficient and ineffective.
The incoming Biden administration offers hope that efforts can be turned around, but the concrete strategies to accomplish the turn-around are yet to be detailed.
To simplify vaccine data systems, I propose a national vaccine registry that tracks vaccination records across the country.
What would a national vaccine registry look like, and how would such a system help public health officials with their vaccine efforts?
Do you agree or disagree with creating a National Vaccine Registry? Read the 400+ comments below and add your own.
The most straightforward aspect of the national vaccine registry would be managing records for who has received the vaccine and who has not.
If the U.S. government anticipates vaccinating all 300 million-plus Americans, there must be a standardized system to keep tabs on who has received their shots.
A method for tracking vaccines nationwide exists in Operation Warp Speed’s Tiberius, but the path for data to reach this system is fragmented.
After a patient has their vaccine administered, a physician inputs their data into their state’s immunization information systems, which takes several steps between the CDC, state health officials, commercial distribution centers, mass data storage centers and more before it reaches Tiberius.
The process needs to be simplified and streamlined. Physicians must be able to upload vaccine data directly to a national registry and associate the patient’s social security number with a vaccine ID.
This would produce an accurate and continuously updated track of who is vaccinated and who is not.
The registry comes with secondary benefits. Associating patients with a vaccine ID means we could have national data on vaccine efficacy. Physicians could update vaccine ID profiles if a patient comes back with COVID-19 symptoms after being vaccinated.
Then we could see which vaccine they took and oversee long-term efficacy by the vaccine manufacturer. This would also present the opportunity to track long-term antibody duration and analyze that data based on demographic information …
William Haseltine is president of ACCESS Health International. An infectious disease expert, Haseltine was formerly a Harvard Medical School professor and founder of the university’s cancer and HIV/AIDS research departments. Click source below to read more.
